---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-075434"
form_type: "8-K"
ticker: "ZLAB"
cik: "0001704292"
company_name: "Zai Lab Ltd"
filed_at: "2022-03-15T23:59:59+00:00"
generated_at: "2026-06-26T22:50:39.708571+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zai Lab appoints Joshua Smiley as COO effective August 1, 2022

## Summary
- Joshua Smiley appointed Chief Operating Officer, effective August 1, 2022, reporting to CEO Samantha Du.
- Smiley brings 26 years biopharma experience, most recently as SVP and CFO at Eli Lilly.
- He will oversee business, finance, and global operations; based in Cambridge, Massachusetts.
- CEO Dr. Du said Smiley will be instrumental in expanding geographies and diversifying financial footprint.

## SEC filing metadata
- accession: 0001193125-22-075434
- form_type: 8-K
- ticker: ZLAB
- cik: 0001704292
- company_name: Zai Lab Ltd
- filed_at: 2022-03-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704292/000119312522075434/0001193125-22-075434-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704292/000119312522075434/d286144d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-075434
- JSON: https://secwatch.observer/filing/0001193125-22-075434.json
- Plain text: https://secwatch.observer/filing/0001193125-22-075434.txt

## Key facts
- Executive change
  Joshua Smiley was appointed as Chief Operating Officer at Zai Lab Ltd.
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On March 15, 2022, Zai Lab Limited (the “Company”) announced the appointment of Joshua Smiley as the Company’s Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704292/000119312522075434/0001193125-22-075434-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.